Doxorubicin loaded magneto-niosomes for targeted drug delivery

Colloids and Surfaces B: Biointerfaces

Volumn 102, Issue , 2013, Pages 803-807

  Tavano, Lorena ^a   Vivacqua, Marco ^a   Carito, Valentina ^a   Muzzalupo, Rita ^a   Caroleo, Maria Cristina ^a   Nicoletta, Fiore ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

Author keywords

Cytotoxicity; Doxorubicin; Ferrofluid; Niosomes; Release

Indexed keywords

BILAYER COMPOSITIONS; DOXORUBICIN; ENTRAPMENT EFFICIENCY; FERROFLUID; IN-VITRO; MAGNETIC DRUG TARGETING; MODEL DRUGS; NIOSOMES; PHYSICOCHEMICAL PROPERTY; PLURONIC L64; RELEASE; TARGETED DRUG DELIVERY; TRYPAN BLUE DYE;

BROMINE COMPOUNDS; CHEMICAL PROPERTIES; CHEMOTHERAPY; CYTOTOXICITY; DRUG DELIVERY; TISSUE;

MAGNETOS;

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; DOXORUBICIN; NIOSOME; POLOXAMER; POLYSORBATE 60; TRYPAN BLUE;

ARTICLE; CELL VIABILITY; CHEMICAL COMPOSITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DELAYED DRUG RELEASE; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG TARGETING; ENCAPSULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL LINE; MAGNETIC FIELD; PHYSICAL CHEMISTRY; PRIORITY JOURNAL;

CELL LINE, TUMOR; CELL SURVIVAL; DOXORUBICIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; LIPOSOMES; MICROSCOPY, ELECTRON, TRANSMISSION; POLOXAMER; POLYSORBATES; SURFACE-ACTIVE AGENTS;

EID: 84867780129     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2012.09.019     Document Type: Article

References (52)

1. Suzuki R., Takizawa T., Kuwata Y., Mutoh M., Ishiguro N., Utoguchi N., Shinohara A., Eriguchi M., Yanagie H., Maruyama K. Int. J. Pharm. 2008, 346:143.
2. Torchilin V.P. Eur. J. Pharm. Sci. 2000, 11:81.
3. Torchilin V.P. Adv. Drug Deliv. Rev. 2005, 57:95.
4. Kim J.S., Rieter W.J., Taylor K.M.L., An H., Lin W.L., Lin W.B. J. Am. Chem. Soc. 2007, 129:8962.
5. Gruttner C., Muller K., Teller J., Westphal F., Foreman A., Ivkov R. J. Magn. Magn. Mater. 2007, 311:181.
6. Lu A., Salabas E.L., Schuth F. Angew. Chem. Int. Ed. 2007, 46:1222.
7. Yu M.K., Jeong Y.Y., Park J., Park S., Kim J.W., Min J.J. Angew. Chem. Int. Ed. 2008, 47:5362.
8. Giri J., Pradhan P., Somani V., Chelawat H., Chhatre S., Banerjee R., Bahadur D. J. Magn. Magn. Mater. 2008, 320:724.
9. Schneider G., Decher G. Nano Lett. 2004, 4:1833.
10. Jun Y., Huh Y.M., Choi J., Lee J.H., Song H.T., Kim S., Yoon S., Kim K.S., Shin J.S., Suh J.S., Cheon J. J. Am. Chem. Soc. 2005, 127:5732.
11. Neuberger T., Schopf B., Hofmann H., Hofmann M., von Rechenberg B. J. Magn. Magn. Mater. 2005, 293:483.
12. Zhou X., Xing D., Zhu D., Jia L. Electrochem. Commun. 2008, 10:564.
13. Hafeli U.O., Riffle J.S., Harris-Shekhawat L., Carmichael-Baranauskas A., Mark F., Dailey J.P., Bardenstein D. Mol. Pharm. Mol. Pharm. 2009, 6:1417.
14. Widder K.J., Senyei A.E., Scarpelli D.G. Proc. Soc. Exp. Biol. Med. 1978, 158:141.
15. Mosbach K., Schroder U. FEBS Lett. 1979, 102:112.
16. Ito A., Shinkai M., Honda H., Kobayashi T. J. Biosci. Bioeng. 2005, 100:1.
17. Mornet S., Vasseur S., Grasset F., Veverka P., Goglio G., Demourgues A., Portier J., Pollert E., Duguet E. Prog. Solid State Chem. 2006, 34:237.
18. Gonzales M., Krishnan K.M. J. Magn. Magn. Mater. 2005, 293:265.
19. Pradhan P., Giri J., Banerjee R., Bellare J., Bahadur D. J. Magn. Magn. Mater. 2007, 311:208.
20. Scientific and Clinical Applications of Magnetic Carriers 1997, 517. Plenum, New York. M. Zborowki (Ed.).
21. Kiwada H., Sato J., Yamada S., Kato Y. Chem. Pharm. Bull. 1986, 34:4253.
22. Kikumori T., Kobayashi T., Sawaki M., Imai T. Cancer Res. Treat. 2009, 113:435.
23. Pradhan P., Banerjee R., Bahadur D., Koch C., Mykhaylyk O., Plank C. Methods Mol. Biol. 2010, 605:279.
24. Kubo T., Sugita T., Shimose S., Nitta Y., Ikuta Y., Murakami T. Int. J. Oncol. 2000, 17:309.
25. Moghimi S.M. FEBS Lett. 2003, 540:241.
26. Plassat V., Martina M.S., Barratt G., Menager C., Lesieur S. Int. J. Pharm. 2007, 344:118.
27. Woodle M.C., Newman M.S., Martin F.J. Int. J. Pharm. 1992, 88:327.
28. Bangham A.D., Standish M.M., Watkins J.C. J. Mol. Biol. 1965, 13:238.
29. Tavano L., Muzzalupo R., Cassano R., Trombino S., Ferrarelli T., Picci N. Coll. Surf. B: Biointerfaces 2010, 75:319.
30. Provencher S.W. Comput. Phys. Commun. 1982, 27:213.
31. Provencher S.W. Comput. Phys. Commun. 1982, 27:229.
32. Tavano L., Muzzalupo R., Cassano R., Trombino S., Ferrarelli T., Picci N. Coll. Surf. B: Biointerfaces 2009, 1:319.
33. Fenton R.R., Easdable W.J., Meng H., Omara E.S.M., Mckeage M.J., Russel P.J., Hambley T.W. J. Med. Chem. 1997, 40:1090.
34. Mosmann T. J. Immunol. Methods 1983, 65:55.
35. Haley B., Frenkel E. Urol. Oncol. 2008, 26:57.
36. Allen T.M., Cullis P.R. Science 2004, 303:1818.
37. Shinkai M., Ito A. Adv. Biochem. Eng. Biotechnol. 2004, 91:19.
38. Nobuto H. Int. J. Cancer 2004, 109:627.
39. Nowicka A.M., Kowalczyk A., Donten M., Krysinski P., Stojek Z. Anal. Chem. 2009, 81:7474.
40. Muzzalupo R., Tavano L., Oliviero C., Cassano R., Trombino S., Picci N. Langmuir 2009, 25:1800.
41. Charman S.A., Mason K.L., Charman W.N. Pharm. Res. 1993, 10:954.
42. Feng M., Morales A.B., Poot A., Beugeling T., Bantjes A.J. Biomater. Sci. Polym. Ed. 1995, 7:415.
43. Muzzalupo R., Tavano L., Cassano R., Trombino S., Cilea A., Picci N. Eur. Polym. J. 2010, 46:209.
44. Koffi A.A., Agnely F., Ponchel G., Grossiord J.L. Eur. J. Pharm. Sci. 2006, 27:328.
45. Muzzalupo R., Tavano L., Cassano R., Trombino S., Ferrarelli T., Picci N. Eur. J. Pharm. Biopharm. 2011, 79:28.
46. Uchegbu I.F., Florence A.T. Adv. Colloid Interface Sci. 1995, 58:1.
47. Tavano L., Muzzalupo R., Trombino S., Cassano R., Pingitore A., Picci N. Coll. Surf. B: Biointerfaces 2010, 79:227.
48. Uchegbu I., Vyas S.P. Int. J. Pharm. 1998, 172:33.
49. Hughes G.A. Nanomedicine: Nanotechnology. Biology, and Medicine 2005, 1:22.
50. Hossann M., Wang T., Wiggenhorn M., Schmidt R., Zengerle A., Winter G., Eibl H., Peller M., Reiser M., Issels R.D., Lindner L.H. J. Contr. Rel. 2010, 147:436.
51. El-Laithy H.M., Shoukry Omar, Mahran L.G. Eur. J. Pharm. 2011, 77:43.
52. Hao Y.M., Li K. Int. J. Pharm. 2011, 403:245.